Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin augmentation of sertraline for major depressive disorder
IRCT2016082829556N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Aspirin + sertraline with Placebo + sertraline (2 arms). Started Sep 2016; status: completed.
02
Drugs
aspirinsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT2016082829556N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016082829556N1.